Catheter Precision Reports Preliminary Q2 Revenue Of $1.037M
Catheter Precision, Inc. (VTAK: NYSE/American), today announced preliminary unaudited record revenues of $1,037,000 for the quarter ended June 30, 2026, including both the MedTech segment and the Flyte Vision Jet
